Exploiting the Ubiquitin-Proteasome Pathway for Anticancer Drug Discovery: Unanswered Questions and Future Directions

E-ISSN： 1875-628x|2|1|74-81

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.2, Iss.1, 2005-02, pp. : 74-81

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial(Hot Topic:Targeting the Ubiquitin-Proteasome Pathway - Current Perspectives and Future Directions)

Current Pharmaceutical Design, Vol. 19, Iss. 18, 2013-06 ,pp. : 3173-3174

Bentham Science Publishers

Access to resources Recommend Favorite

Natural Products Inhibiting the Ubiquitin-Proteasome Proteolytic Pathway, A Target for Drug Development

Current Medicinal Chemistry, Vol. 13, Iss. 7, 2006-03 ,pp. : 745-754

Bentham Science Publishers

Access to resources Recommend Favorite

The ubiquitin–proteasome pathway in viral infections

By Gao Guang Luo Honglin

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 1, 2006-01 ,pp. : 5-14

NRC Research Press

Access to resources Recommend Favorite

Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System

Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. : 517-536

Bentham Science Publishers

Access to resources Recommend Favorite

Natural Product Inhibitors of the Ubiquitin-Proteasome Pathway

Current Drug Targets, Vol. 12, Iss. 11, 2011-10 ,pp. : 1581-1594

Bentham Science Publishers

Access to resources Recommend Favorite